Diverse molecular data demonstrate that commercially available medicinal leeches are not Hirudo medicinalis.
The European medicinal leech is one of vanishingly few animal species with direct application in modern medicine. In addition to the therapeutic potential held by many protease inhibitors purified from leech saliva, and notwithstanding the historical association with quackery, Hirudo medicinalis has been approved by the United States Food and Drug Administration as a prescription medical device. Accurate annotation of bioactive compounds relies on precise species determination. Interpretations of developmental and neurophysiological characteristics also presuppose uniformity within a model species used in laboratory settings. Here, we show, with mitochondrial sequences and nuclear microsatellites, that there are at least three species of European medicinal leech, and that leeches marketed as H. medicinalis are actually Hirudo verbana. Beyond the obvious need for reconsideration of decades of biomedical research on this widely used model organism, these findings impact regulatory statutes and raise concerns for the conservation status of European medicinal leeches.
Siddall
Mark E
ME
Division of Invertebrate Zoology, American Museum of Natural History, New York, NY 10024, USA. siddall@amnh.org
Trontelj
Peter
P
Utevsky
Serge Y
SY
Nkamany
Mary
M
Macdonald
Kenneth S
KS
D000483:Alleles; D000704:Analysis of Variance; D000818:Animals; D001483:Base Sequence; D003132:Commerce; D017931:DNA Primers; D004272:DNA, Mitochondrial / Q000235:genetics; D005060:Europe; D007865:Leeches / Q000145:classification* / Q000235:genetics*; D018895:Microsatellite Repeats / Q000235:genetics; D008957:Models, Genetic; D008969:Molecular Sequence Data; D010802:Phylogeny; D017422:Sequence Analysis, DNA; D013045:Species Specificity
D017931:DNA Primers; D004272:DNA, Mitochondrial